Neurocrine Biosciences
Clinical trials sponsored by Neurocrine Biosciences, explained in plain language.
-
Study tests Long-Term safety of new drug for severe childhood epilepsy
Disease control TerminatedThis study aimed to check the long-term safety and side effects of the drug NBI-827104 in children with a rare and severe form of epilepsy. It was an extension study for children who had already taken part in a previous trial, but also allowed some new participants. The main goal…
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope for controlling rare childhood epilepsy
Disease control TerminatedThis study tested whether adding a new drug called NBI-921352 to a patient's current seizure medications could help reduce seizure frequency in children and young adults with a rare genetic epilepsy called SCN8A-DEE. It was a Phase 2 trial that compared the drug to a placebo (ina…
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC